Education
- PhD, Health Policy (Economics Track), University of California at Berkeley, 2016
- MS, Economics, University of California at Berkeley, 2015
- MA, International Comparative Education, Stanford University, 2009
- BA, Economics and English, Peking University, China, 2008
Courses Taught
- HEOR 597: Graduate Seminar
- HEOR 598: HEOR Methodologies Seminar
Research Interests
- Decision-making in Aging
- Physician Behavior
- Policy Evaluation
- Experimental and Quasi-experimental Methods
Biography
Dr. Jing Li is a health economist with research interests in the economic, social and behavioral factors affecting individual decision-making in health and healthcare, for both providers and patients, and the impact of policies that leverage these factors to improve patient outcomes and healthcare market efficiency. Methodologically, she is interested in innovatively applying advanced experimental and econometric methods to addressing understudied questions in health economics and policy. Dr. Li’s current projects study experimentally measured social preferences (altruism) of physicians and their relationship with patient outcomes, healthcare and financial decision-making for older adults with cognitive impairments including Alzheimer’s disease and related dementias, and conflicts of interest in physician drug prescribing.
Selected Publications
https://www.ncbi.nlm.nih.gov/myncbi/jing.li.13/bibliography/public/
Education
- PhD in Social & Administrative Pharmacy, University of Minnesota
- MS in Pharmacy Administration, University of Minnesota
- BPharm Pharmacy, Washington State University
Courses Taught
- Pharm 581/GH 543: Global Health Pharmacy
- Pharm 582/GH 590: Global Pharmacovigilance
Biography
Andy Stergachis is Professor of Pharmacy and Global Health and Adjunct Professor of Health Services and Epidemiology, Associate Dean, School of Pharmacy, and Director of the Global Medicines Program, University of Washington. He is an author of over 160 peer-reviewed publications in areas such as drug safety, pharmaceutical outcomes, and clinical epidemiology and served as Editor-in-Chief of the Journal of the American Pharmacists Association. He is an elected member of the National Academies of Medicine. He served on the Drug Safety and Risk Management Advisory Committee for the US FDA, Malaria in Pregnancy Consortium Safety Working Group, the Advisory Group to Global Alert and Response for the WHO, the Access and Product Management Advisory Committee for Medicines for Malaria Venture, and the Bill & Melinda Gates Foundation Safety Surveillance Working Group. He is Chair of the Expert Panel to Review Surveillance and Screening Technologies for the Quality Assurance of Medicines for United States Pharmacopeia, He is a Fellow of the International Society for Pharmacoepidemiology and a Fellow of the American Pharmacists Association. Since 2010, He has chaired 7 PhD student doctoral dissertation committees (Epidemiology and Pharmacy), mentored postdoctoral trainees, served on numerous graduate student PhD dissertation and MPH thesis committees, and served as advisor to multiple graduate students.
Dr. Stergachis’ research focus is pharmacoepidemiology, global medicines safety, pharmaceutical outcomes research, and public health systems research. He directed a pharmacovigilance pregnancy registry study on the safety of first trimester antimalarials conducted in three sub-Saharan African countries and has developed novel approaches for HIV pharmacovigilance and strengthening pharmacy services in LMICs. He is currently PI of the University of Washington component of a pharmacovigilance project funded by the Bill & Melinda Gates Foundation. He is the PI of the UW component of a USAID-funded cooperative agreement with Management Sciences for Health on the Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program. He is a co-investigator on a project with the Institute for Health Metrics and Evaluation (IHME) on mapping and monitoring the global burden of antimicrobial resistance. Through his affiliation with the Northwest Center for Public Health Practice, he also works on workforce development and research in emergency preparedness with the public health community.